Variant report
Variant | esv3693279 |
---|---|
Chromosome Location | chr2:53844902-53846547 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:53838050..53841676-chr2:53842441..53845129,3 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GPR75-5 | chr2:53843602-53845521 | ucscGeneNc_uc002rxj_1 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6545358 | chr2:53844902-53844903 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs116758146 | chr2:53844913-53844914 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs190986544 | chr2:53844972-53844973 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs71413243 | chr2:53844987-53844988 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs531398164 | chr2:53845124-53845125 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs534159407 | chr2:53845133-53845134 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs114800538 | chr2:53845150-53845151 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs574142238 | chr2:53845158-53845159 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs6748765 | chr2:53845228-53845229 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs555536237 | chr2:53845234-53845235 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs575382665 | chr2:53845268-53845269 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs114338359 | chr2:53845291-53845292 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs564010643 | chr2:53845317-53845318 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs371863978 | chr2:53845339-53845340 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs556940403 | chr2:53845360-53845361 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs538579860 | chr2:53845405-53845406 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs558152890 | chr2:53845420-53845421 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs539799518 | chr2:53845442-53845443 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs571839463 | chr2:53845468-53845469 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs559718236 | chr2:53845519-53845520 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs528950493 | chr2:53845520-53845521 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs530011959 | chr2:53846202-53846203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550162304 | chr2:53846264-53846265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570009730 | chr2:53846266-53846267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373083904 | chr2:53846267-53846268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557526776 | chr2:53846328-53846329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571147965 | chr2:53846349-53846350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533819261 | chr2:53846356-53846357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553679708 | chr2:53846359-53846360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577840767 | chr2:53846396-53846397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs141687555 | chr2:53846404-53846405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112581426 | chr2:53846438-53846439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs116567766 | chr2:53846440-53846441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188274443 | chr2:53846447-53846448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576011227 | chr2:53846449-53846450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545173586 | chr2:53846450-53846451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs6753333 | chr2:53846456-53846457 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs116228652 | chr2:53846461-53846462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35697771 | chr2:53846465-53846466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192170561 | chr2:53846466-53846467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs34722939 | chr2:53846488-53846489 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs10167220 | chr2:53846489-53846490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549860405 | chr2:53846501-53846502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529502605 | chr2:53846528-53846529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6753258 | chr2:53846547-53846548 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:53846200-53846600 | Enhancers | Fetal Heart | heart |
2 | chr2:53846200-53847600 | Enhancers | Fetal Brain Male | brain |
3 | chr2:53846400-53846800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr2:53846400-53847400 | Enhancers | Brain Cingulate Gyrus | brain |